Skip to content

Public FDA record

Z-0470-06: Sickle-STAT Test Kit, Catalog # SC901, a qualitative test kit for the determination of the presence of he

Recall record Z-0470-06 for Chembio Diagnostic System Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0470-06
Company in FDA record
Chembio Diagnostic System Inc
FDA classification date
Feb 4, 2006
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Firm received one report of a false negative with the positive control. Internal testing by the firm has shown that the kit lot may result in invalid or false negative interpretations.

Source facts

Action
Chembio phoned the consignees and followed up by faxing the recall letters (dated 12/15/05) & response forms on 12/22/05.
Initiated
2005-12-16
Root cause
Other
Terminated
2006-06-30
Distribution
Medical facilities and a few distributors located nationwide, the Dominican Republic, and West Indies (St. Vincent & Grenadine)
Recall number
Z-0470-06
Recall status
Terminated
CDRH record ID
43381
FDA classified
2006-02-04
Recall event number
34263

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗